Actuate Therapeutics Inc (ACTU)
ACTU Stock Price Chart
Explore Actuate Therapeutics Inc interactive price chart. Choose custom timeframes to analyze ACTU price movements and trends.
ACTU Company Profile
Discover essential business fundamentals and corporate details for Actuate Therapeutics Inc (ACTU) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Aug 2024
Employees
10.00
Website
https://actuatetherapeutics.comCEO
Daniel Schmitt
Description
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
ACTU Financial Timeline
Browse a chronological timeline of Actuate Therapeutics Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.21.
Earnings released on 14 May 2026
EPS came in at -$0.24 falling short of the estimated -$0.23 by -4.35%.
Earnings released on 26 Mar 2026
EPS came in at -$0.18 surpassing the estimated -$0.24 by +25.00%.
Earnings released on 13 Nov 2025
EPS came in at -$0.25 surpassing the estimated -$0.27 by +7.41%.
Earnings released on 14 Aug 2025
EPS came in at -$0.30 falling short of the estimated -$0.19 by -57.89%.
Earnings released on 15 May 2025
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%.
Earnings released on 13 Mar 2025
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%.
Earnings released on 13 Nov 2024
EPS came in at -$0.55 matching the estimated -$0.55.
Earnings released on 24 Sept 2024
EPS came in at -$4.20 .
Earnings released on 31 Mar 2024
EPS came in at -$0.54 .
Earnings released on 31 Dec 2023
EPS came in at -$0.50 .
Earnings released on 30 Sept 2023
EPS came in at -$0.41 .
Earnings released on 30 Jun 2023
EPS came in at -$0.39 .
Earnings released on 31 Mar 2023
EPS came in at -$0.39 .
ACTU Stock Performance
Access detailed ACTU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
